IGBA Puts Together Global Leadership Alliance
CEO Advisory Committee Provides Forum For Leaders To Engage On Key Issues
Executive Summary
Leaders from a host of the world’s top generics and biosimilars companies have come together as part of a CEO advisory committee put together by the IGBA. The committee is expected to provide a forum to share thinking on key issues affecting the off-patent industry and best position the industry on critical policy issues with a single collective voice.
You may also be interested in...
IGBA CEO Panel Sets Out Priorities For Supply-Chain Resilience
After a meeting in Vienna, the IGBA’s CEO advisory committee has outlined four key areas in which action is needed to bolster supply-chain security and ensure pandemic prevention, preparedness and response.
Wave Of New Leaders Could Reshape Generics Industry
With a number of top generics and biosimilars firms announcing new leaders over the past few months, the industry could be in for some strategic shifts as new faces take the helm at established off-patent players.
In Quick Succession: Wave Of New Leaders Could Reshape Industry
With a number of top generics and biosimilars firms announcing new leaders over the past few months, the industry could be in for some strategic shifts as new faces take the helm at established off-patent players.